Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 19, 2024
Catalent, Inc. and Novo Holdings A/S announced that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a total enterprise value of approximately $16.5 billion.
read more
Novavax and FUJIFILM Diosynth Biotechnologies has announced an agreement to manufacture bulk drug substance for NVX-CoV2373, Novavax' COVID-19 vaccine candidate.
read more
Catalent’s Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities.
read more
Novatek International has been selected by Boehringer Ingelheim as their approved Vendor and Partner for a worldwide solution for Environmental Monitoring Software.
read more
Novatek requalified as an approved supplier for Boehringer Ingelheim, a global leader in healthcare. Novatek regulatory compliant quality solutions are used at Boehringer Ingelheim for its human pharma, animal health and biopharmaceutical aseptic ...
read more
The Novasep-PharmaZell Group has announced a €7.3M investment for its Mourenx site (southwestern France), as part of a larger project supported by the "France Relance" Plan, to create a multipurpose pilot workshop within one of its production units.
read more
Tuesday, November 10, 2020
Novasep is investing €6.5 million to expand capacity & increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site.
read more
Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group's corporate quality director and a member of Novasep's executive ...
read more
Wednesday, December 13, 2017
Samsung BioLogics has been licensed by the Europe’s EMA for the first monoclonal antibody Drug Substance at its second plant.
read more
Novasep, a supplier of services and technologies for the life sciences industry, has finalized the set-up of its new synthesis laboratory and kilo lab at its US facility. Production of kilogram scale batches of synthetic molecules for biological ...
read more
Novasep announced its API development and manufacturing site in Chasse-sur-Rhône, France, has been successfully inspected by the FDA.
read more
Thursday, December 09, 2021
Novasep, a supplier of services and technologies for the life sciences industry, has announced a €6 million investment on its Chasse-sur-Rhône site, France (38). This investment will increase and modernize its manufacturing capabilities to support ...
read more
Novasep, a supplier of services and technologies for the life sciences industry, announced a €6.1 million investment at its Mourenx facility(Pyrénées-Atlantiques – France). This investment will modernize its API manufacturing facility.
read more
Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients manufacturing capabilities on its Le Mans site.
read more
Novasep, a supplier of services and technologies for the life sciences industry, has announced the appointment of Xavier de Saint Guilhem as Chief Financial Officer.
nitially trained at ENSCP, MIT (Massachusetts Institute of Technology) and INSEAD, ...
read more